Pharmacokinetics and Ex Vivo Pharmacodynamic Antimalarial Activity of Dihydroartemisinin-Piperaquine in Patients with Uncomplicated Falciparum Malaria in Vietnam
Author(s) -
Dao Van Hoang Nguyen,
Quoc P. Nguyen,
Ngoa Dang Nguyen,
Thuy Thi Le,
The Duy Nguyen,
Duy Ngoc Dinh,
Thanh Xuân Nguyễn,
Bui Dai,
Marina Chavchich,
Michael D. Edstein
Publication year - 2009
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.01717-08
Subject(s) - dihydroartemisinin , piperaquine , malaria , pharmacokinetics , pharmacology , medicine , plasmodium falciparum , pharmacodynamics , ex vivo , artemisinin , in vivo , biology , immunology , microbiology and biotechnology
Compared to healthy subjects, malaria patients show a reduction in the mean oral clearance (1.19 versus 5.87 liters/h/kg of body weight) and apparent volume of distribution (1.47 versus 8.02 liters/kg) of dihydroartemisinin in Vietnamese patients following treatment with dihydroartemisinin-piperaquine (Artekin) for uncomplicated Plasmodium falciparum. Dihydroartemisinin is responsible for most of the ex vivo antimalarial activity of dihydroartemisinin-piperaquine.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom